About Laminar research
Export > X-Plane Object (.obj)2. Set the export destination to …\X-Plane 11\Aircraft\Laminar Research\Cessna 172SP\objects3. No need to change the default export name as the name of the final OBJ has been previously defined in the Scene Root Collection PropertiesOption 2) You could also click on the Export OBJs on top of the Scene X-Plane Properties (where you defined the name and textures), however you cannot save where the OBJs will be exported, it will always be exported exactly where your .blend file has been saved.9. Save your file! You can check my exported OBJ file version TEST CUBE BLENDER_EXPORT_1.obj Examining the exported OBJsLet’s make sure that the OBJs got exported the right way. This is an important step especially if you are exporting it for the first time. You want to make sure it is exported right, so that you don’t have to wonder why something doesn’t look as it should when you import it in X-Plane.1. Go to the export folder (…\X-Plane 11\Aircraft\Laminar Research\Cessna 172SP\objects) and open the TEST CUBE AC3D.obj / TEST CUBE BLENDER.obj in any text editor. I use and recommend Notepad++.2. What we want to see is the “TEXTURE fuselage.dds” line, which means this object will load the right texture. AC3D BLENDER 6. Importing the OBJ files into Planemaker1. Open Planemaker.exe from the X-Plane root folder2. File > Open > C:\X-Plane 11\Aircraft\Laminar Research\Cessna 172SP\Cessna_172SP.acf3. Go to Standard > Misc Objects4. On the bottom of the screen, click on Add5. Scroll all the way down, you will find a new undefined object attached 6. Click on the little square next to the empty space, go to …\X-Plane 11\Aircraft\Laminar Research\Cessna 172SP\objects and select TEST CUBE AC3D.obj or TEST CUBE BLENDER.obj, depending on which software you used.I added both, just to demonstrate for both cases.7. Change the location based on the numbers below. AC3D cube is -6m on the Y axis, and Blender cube is +6m on the Y axis. 8. Close this section and you will immediately see that the cube should now be attached to the plane.9. File > Save10. Open X-Plane and load the Cessna Skyhawk
Key features of the Laminar research that are enabled through these drivers include:
- KLM dolphin four-pack for Laminar Research A
- Research begins on laminar flow concept - NASA
- FlightSimExpo 2025: Interview with Laminar Research on X
- [XP12] Laminar Research A Philippine Airlines Livery
- Laminar Research default Cessna 172 classic
- Sappy Founder's Note - by Kit - Laminar Research
- Laminar Research - Crunchbase Company Profile Funding
Investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation Irvine, CA – February 27, 2024 – Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson MedTechi, announced the commencement of patient cases with the investigational Laminar Left Atrial Appendage Elimination (LAAX) System as part of its pivotal investigational device exemption (IDE) study. The first procedures, performed by leading physicians Saibal Kar, MD, FACC, FSCAI, (Program Director, Cardiovascular Disease Fellowship, Los Robles Health System, California, HCA Healthcare National Physician Director, Interventional Cardiology) and Devi Nair, MD, FACC, FHRS, (Director, Cardiac Electrophysiology Division, St. Bernard’s Heart & Vascular Center, Jonesboro, Arkansas) mark a significant milestone in the pursuit of innovative solutions for non-valvular atrial fibrillation (NVAF) treatment.The prospective, randomized, controlled, multicenter, open-label pivotal clinical study aims to enroll 1,500 patients across up to 100 sites in the United States. Patients with NVAF deemed appropriate for LAAX to reduce the risk of stroke and systemic embolism, will participate in this research effort. The study will compare the safety and efficacy of the Laminar LAAX System to commercially available left atrial appendage (LAA) closure devices, providing a potential non-pharmacologic alternative for eligible patients.Dr. Karii, Principal Investigator in the study, shared his positive experience with the Laminar LAAX System: “Los Robles was the leading enrolling site the US Early Feasibility Study (EFS) for this innovative approach to LAA elimination. It’s exciting to be part of the evolution of the latest technology into a tangible solution for treating patients. I look forward to seeing the results from this US clinical trial.” Dr. Nairiii, also a Principal Investigator of the clinical trial, expressed enthusiasm about the potential impact on patients’ lives: “I am excited to be part of
